Abstract:The gene–environment interactions resulting from famine and the subsequent increased intergenerational risk of type 2 diabetes mellitus (T2DM) have contributed to the current epidemic of T2DM in China, which poses major social, health and economic challenges. The epidemic of T2DM could threaten national development in China through premature morbidity and mortality from T2DM and associated non-communicable diseases. The Chinese Famine (1959–1961), as a contributor to the nation’s current national T2DM epidemic, provides an important and urgent public health warning. The effects of the famine give a strong message that research and actions that address the prevention of T2DM cannot be confined to lifestyle measures, as used in the landmark Da Qing study and the lifestyle prevention programmes and pharmaceutical interventions used in Western nations. To stem the T2DM epidemic, a new paradigm for prevention of T2DM must be developed. This paradigm should include a very strong emphasis on pregnancy planning and maternal and child health during and after the pregnancy. Without action, intergenerational cycles initiated by epigenetic modifications resulting from adverse environmental stimuli during the critical window of early development in utero might continue to fuel the T2DM epidemic in future generations. This Review discusses the role of the Chinese Famine in the current epidemic of type 2 diabetes mellitus in China and highlights lessons to be learned.

Author Correction: Epidemic T2DM, Early Development and Epigenetics: Implications of the Chinese Famine

Correction to “gut Microbiota Dysbiosis in Chinese Children with Type 1 Diabetes Mellitus: an Observational Study”

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Correction To: Increase in the Prevalence of Hypertension among Adults Exposed to the Great Chinese Famine During Early Life

Correction to: Epidemiology of diabetes and diabetic complications in China

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction: Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.

Epidemic T2DM, Early Development and Epigenetics: Implications of the Chinese Famine

Correction: Corrigendum: Diabetes Onset at 31–45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes

Correction To: Sex Differences in 10-Year Ischemic Cardiovascular Disease Risk Prediction in Chinese Patients with Prediabetes and Type 2 Diabetes

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Erratum: Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice

Erratum: An innovative state-of-the-art health storytelling technique for better management of type 2 diabetes

Corrigendum: Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: a cross-sectional inpatient study

Erratum. Obese Skeletal Muscle–Expressed Interferon Regulatory Factor 4 Transcriptionally Regulates Mitochondrial Branched-Chain Aminotransferase Reprogramming Metabolome. Diabetes 2022;71:2256–2271

Correction To: Effects of Probiotics on Type II Diabetes Mellitus: a Meta-Analysis

Corrigendum to “the Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials” by Yuqi Liu,Juan Li, Jinfang Ma, Nanwei Tong

Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis

Author Correction: Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects

Author Correction: The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24)